AAAAAA
Results: 1-25/46
Authors:
Schaefer, J
Reichmann, H
Citation: J. Schaefer et H. Reichmann, Mitochondrial diseases, DEUT MED WO, 126(33), 2001, pp. 913-917
Authors:
Gahn, G
Hahn, G
Hallmeyer-Elgner, S
Kunz, A
Straube, T
Bourquain, H
Reichmann, H
von Kummer, R
Citation: G. Gahn et al., Echo-enhanced transcranial color-coded duplexsonography to study collateral blood flow in patients with symptomatic obstructions of the internal carotid artery and limited acoustic bone windows, CEREB DIS, 11(2), 2001, pp. 107-112
Authors:
Schmiedel, J
Seibel, P
Reichmann, H
Citation: J. Schmiedel et al., Molecular biological diagnostics of metabolic myopathies, AKT NEUROL, 28(5), 2001, pp. 208-213
Authors:
Schafer, J
Reichmann, H
Citation: J. Schafer et H. Reichmann, Sports in metabolic myopathies, AKT NEUROL, 28(1), 2001, pp. 26-30
Authors:
Mungersdorf, M
Sommer, U
Sommer, M
Reichmann, H
Citation: M. Mungersdorf et al., High-dose therapy with ropinirole in patients with Parkinson's disease, J NEURAL TR, 108(11), 2001, pp. 1309-1317
Authors:
Damian, MS
Sauter, W
Reichmann, H
Citation: Ms. Damian et al., Subcutaneous microdialysis in mitochondrial cytopathy, MUSCLE NERV, 24(5), 2001, pp. 648-653
Authors:
Gotz, ME
Janetzky, B
Pohli, S
Gottschalk, A
Gsell, W
Tatschner, T
Ransmayr, G
Leblhuber, F
Gerlach, M
Reichmann, H
Riederer, P
Boning, J
Citation: Me. Gotz et al., Chronic alcohol consumption and cerebral indices of oxidative stress: Is there a link?, ALC CLIN EX, 25(5), 2001, pp. 717-725
Authors:
Lampe, JB
Hindinger, C
Reichmann, H
Citation: Jb. Lampe et al., Intrathecal methylprednisolone for postherpetic neuralgia, N ENG J MED, 344(13), 2001, pp. 1019-1020
Authors:
Lampe, J
Gossrau, G
Reichmann, H
Walter, MC
Mendel, B
Lochmuller, H
Citation: J. Lampe et al., Prion codon 129 homozygosity and sporadic inclusion body myositis, NEUROLOGY, 57(2), 2001, pp. 368-368
Authors:
Lampe, J
Gossrau, G
Reichmann, H
Koch, R
Walter, MC
Mendel, B
Lochmuller, H
Citation: J. Lampe et al., Prion codon 129 homozygosity and sporadic inclusion body myositis, NEUROLOGY, 57(2), 2001, pp. 368-368
Authors:
Damian, MS
Gerlach, A
Schmidt, F
Lehmann, E
Reichmann, H
Citation: Ms. Damian et al., Modafinil for excessive daytime sleepiness in myotonic dystrophy, NEUROLOGY, 56(6), 2001, pp. 794-796
Authors:
Kornblum, C
Broicher, R
Walther, E
Seibel, P
Reichmann, H
Klockgether, T
Herberhold, C
Schroder, R
Citation: C. Kornblum et al., Cricopharyngeal achalasia is a common cause of dysphagia in patients with mtDNA deletions, NEUROLOGY, 56(10), 2001, pp. 1409-1412
Proximal weakness and exercise-induced pain as first symptoms of oculopharyngeal muscular dystrophie
Authors:
Lampe, JB
Schafer, J
Gartner, HJ
Reichmann, H
Citation: Jb. Lampe et al., Proximal weakness and exercise-induced pain as first symptoms of oculopharyngeal muscular dystrophie, NERVENARZT, 72(8), 2001, pp. 652-655
Authors:
Seibel, M
Bachmann, C
Schmiedel, J
Wilken, N
Wilde, F
Reichmann, H
Isaya, G
Seibel, P
Pfeiler, D
Citation: M. Seibel et al., Processing of artificial peptide-DNA-conjugates by the mitochondrial intermediate peptidase (MIP) (vol 380, pg 961, 1999), BIOL CHEM, 381(7), 2000, pp. 633-633
Authors:
Bringmann, G
Feineis, D
Bruckner, R
Blank, M
Peters, K
Peters, EM
Reichmann, H
Janetzky, B
Grote, C
Clement, HW
Wesemann, W
Citation: G. Bringmann et al., Bromal-derived tetrahydro-beta-carbolines as neurotoxic agents: Chemistry,impairment of the dopamine metabolism, and inhibitory effects on mitochondrial respiration, BIO MED CH, 8(6), 2000, pp. 1467-1478
Authors:
Bringmann, G
Feineis, D
God, R
Bruckner, R
Protzen, JA
Blank, M
Peters, K
Peters, EM
Janetzky, B
Reichmann, H
Citation: G. Bringmann et al., Chemical modification of the mitochondrial complex I inhibitor 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline: Synthesis and evaluation of N-alkanoyl derivatives, Z NATURFO C, 55(7-8), 2000, pp. 620-630
Authors:
Gerlach, M
Riederer, P
Reichmann, H
Citation: M. Gerlach et al., Preclinical and clinical aspects of dopamine agonists. What is known for certain?, NERVENHEILK, 19(2), 2000, pp. 53
Authors:
Reichmann, H
Jost, W
Citation: H. Reichmann et W. Jost, Modern concepts in the treatment of patients with idiopathic Parkinson's disease - Introduction, J NEUROL, 247, 2000, pp. 1-1
Authors:
Reichmann, H
Citation: H. Reichmann, Long-term treatment with dopamine agonists in idiopathic Parkinson's disease, J NEUROL, 247, 2000, pp. 17-19
Authors:
Reichmann, H
Sommer, U
Fuchs, G
Hefter, H
Mark, G
Muller, T
Thumler, R
Ulm, G
Vieregge, P
Citation: H. Reichmann et al., Workshop IV: Drug treatment guidelines for the long-term management of Parkinson's disease, J NEUROL, 247, 2000, pp. 40-41
Authors:
Reichmann, H
Janetzky, B
Citation: H. Reichmann et B. Janetzky, Mitochondrial dysfunction - A pathogenetic factor in Parkinson's disease, J NEUROL, 247, 2000, pp. 63-68
Authors:
Damian, MS
Reichmann, H
Citation: Ms. Damian et H. Reichmann, Cerebral edema and raised intracranial pressure - Monitoring and treatmentupdate, AKT NEUROL, 27(8), 2000, pp. 357-364
Authors:
Schaefer, J
Reichmann, H
Citation: J. Schaefer et H. Reichmann, The clinical benefit of genetic studies in neurology, AKT NEUROL, 27(8), 2000, pp. 365-375
Authors:
Reichmann, H
Lachenmayer, L
Citation: H. Reichmann et L. Lachenmayer, The non-ergot-agonist ropinirole in the treatment of Parkinson's disease, AKT NEUROL, 27(7), 2000, pp. 318-324
Authors:
Kramer, C
Reichmann, H
Citation: C. Kramer et H. Reichmann, Neuromuscular disorders and driving licence: Updated guidelines for medico-legal evaluation, AKT NEUROL, 27(5), 2000, pp. 232-233